Riyas Mohamed, F.R.; Aldubaisi, S.; Akbar, A.; Khan, M.I.; Yaqinuddin, A.
Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. Cancers 2025, 17, 2953.
https://doi.org/10.3390/cancers17182953
AMA Style
Riyas Mohamed FR, Aldubaisi S, Akbar A, Khan MI, Yaqinuddin A.
Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. Cancers. 2025; 17(18):2953.
https://doi.org/10.3390/cancers17182953
Chicago/Turabian Style
Riyas Mohamed, Fathima Raahima, Safiah Aldubaisi, Arshiya Akbar, Mohammad Imran Khan, and Ahmed Yaqinuddin.
2025. "Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy" Cancers 17, no. 18: 2953.
https://doi.org/10.3390/cancers17182953
APA Style
Riyas Mohamed, F. R., Aldubaisi, S., Akbar, A., Khan, M. I., & Yaqinuddin, A.
(2025). Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. Cancers, 17(18), 2953.
https://doi.org/10.3390/cancers17182953